NCT05886608View on ClinicalTrials.gov

Evaluation of the Effect of the AI500™ SINGLE-DOSE GEL Medical Device in Patients With Reduced Knee Function

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions

Pain, AcutePain, ChronicKnee InjuriesKnee OsteoarthritisKnee ArthritisKnee Pain Swelling

Interventions

DEVICE

AI 500™ SINGLE-DOSE GEL

AI500™ SINGLE-DOSE GEL is a hydrogel to be applied to intact skin, intended to provide relief in cases of pain due to tension in muscles and adjacent tissues, to improve movement and function.

Trial Locations (1)

20089

Humanitas Research Hospital, Rozzano

All Listed Sponsors

lead

Contrad Swiss SA

INDUSTRY